ePRO Symptom Monitoring for Thoracic Surgery Patients
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores the effectiveness of ePRO monitoring for patients who have undergone major thoracic surgery, involving the chest and lungs. ePRO monitoring requires patients to fill out surveys about their symptoms and physical functioning, which can alert doctors if issues arise. The trial aims to determine if this real-time, remote monitoring can improve recovery. Ideal candidates have had major chest surgery, can complete surveys in English or Spanish, and are recovering at home. As an unphased trial, it offers patients the chance to contribute to innovative research that could enhance recovery experiences for future patients.
Do I need to stop my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that ePRO monitoring is safe for thoracic surgery patients?
Research has shown that ePRO monitoring is generally easy for patients to use. Patients fill out surveys online or by phone to report their symptoms. Studies have found that this type of monitoring can be helpful for people with cancer and other conditions, as it tracks symptoms and alerts healthcare providers to any concerning changes.
One study examined ePRO combined with vital sign monitoring and assessed its safety and effectiveness. It found that this approach can improve patients' quality of life. The system allows real-time tracking, enabling doctors to respond quickly if needed.
Overall, ePRO monitoring is considered safe and useful. It helps patients communicate health changes to their care team easily and quickly.12345Why are researchers excited about this trial?
Researchers are excited about ePRO Monitoring for thoracic surgery patients because it offers a novel way to track symptoms remotely using web-based or telephone surveys. Unlike traditional follow-ups that require in-person visits, this approach allows for continuous and real-time monitoring of patient well-being from the comfort of their home. This can lead to quicker detection of post-surgery complications and more personalized care, potentially improving recovery outcomes and patient satisfaction.
What evidence suggests that ePRO monitoring is effective for thoracic surgery patients?
Research has shown that electronic patient-reported outcome (ePRO) monitoring can enhance care for patients who have undergone thoracic surgery. In one study, patients used ePRO to report symptoms electronically, enabling doctors to respond quickly to issues. Another study found that patients using ePRO became more involved in their recovery, leading to better overall outcomes. This trial will involve thoracic surgery patients using ePRO monitoring through web-based or telephone surveys. These findings suggest that ePRO monitoring effectively supports patients after thoracic surgery by keeping doctors informed and engaged in real-time.678910
Who Is on the Research Team?
Gita Mody, MD, MPH
Principal Investigator
University of North Carolina, Chapel Hill
Are You a Good Fit for This Trial?
This trial is for adults who've had or will have major thoracic surgery, can complete surveys in English or Spanish, and are not pregnant. Excluded are those with minor surgeries, mental conditions affecting consent, prisoners, or if the surgery didn't happen within 3 months after consent.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Implementation
Implementation of ePRO monitoring for thoracic surgery patients
Monitoring
Participants are monitored using ePRO surveys to track symptoms and trigger alerts
Follow-up
Participants are monitored for safety and effectiveness after the main monitoring phase
What Are the Treatments Tested in This Trial?
Interventions
- ePRO Monitoring
Find a Clinic Near You
Who Is Running the Clinical Trial?
UNC Lineberger Comprehensive Cancer Center
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator